EUVIMEDEUVIMED entdecken
Crossref

Machine Learning‐Engineered Nanozyme System for Synergistic Anti‐Tumor Ferroptosis/Apoptosis Therapy

Tianliang Li, Bin Cao, Tianhao Su, Lixing Lin, Dong Wang, Xinting Liu, Haoyu Wan, Haiwei Ji, Zixuan He, Yingying Chen, Lingyan Feng iD, Tong-Yi Zhang

Small · 2025-02 · 21 (5)

DOI: 10.1002/smll.202408750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 16.12.2024. Verfasst von Tianliang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Materials Genome Institute, Shanghai Engineering Research Center for Integrated Circuits and Advanced Display Materials, and Shanghai Engineering Res…. Hauptthemen laut MEDLINE: Ferroptosis, Apoptosis, Machine Learning. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for Distinguished Professor of Shanghai Universities (Oriental Scholars), Guangzhou-HKUST(GZ) Joint Funding Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanozymes with multienzyme‐like activity have sparked significant interest in anti‐tumor therapy via responding to the tumor microenvironment (TME). However, the consequent induction of protective autophagy substantially compromises the therapeutic efficacy. Here, a targeted nanozyme system (Fe‐Arg‐CDs@ZIF‐8/HAD, FZH) is shown, which enhances synergistic anti‐tumor ferroptosis/apoptosis therapy by leveraging machine learning (ML). A novel ML model, termed the sequential backward Tree‐Classifier for Gaussian Process Regression (TCGPR), is proposed to improve data pattern recognition following the divide‐and‐conquer principle. Based on this, a Bayesian optimization algorithm is employed to select candidates from the extensive search space. Leveraging this fresh material discovery framework, a novel strategy for enhancing nanozyme‐based tumor therapy, has been developed. The results reveal that FZH effectively exerts anti‐tumor effects by sequentially responding to the TME, having a cascade reaction to induce ferroptosis. Moreover, the endogenous elevation of high concentration nitric oxide (NO) serves as a direct mechanism for killing tumor cells while concurrently suppressing the protective autophagy induced by oxidative stress (OS), enhancing synergistic ferroptosis/apoptosis therapy. Overall, a novel strategy for improving nanozyme‐based tumor therapy has been proposed, underlying the integration of ML, experiments, and biological applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisApoptosisMachine LearningHumansCell Line, TumorAutophagyAnimalsTumor Microenvironment

Stichwörter der Autor:innen

NO therapyfunctionalized carbon dotsmachine learningnanozymetumor microenvironment‐response

Autor:innen und Institutionen

  • Materials Genome Institute, Shanghai Engineering Research Center for Integrated Circuits and Advanced Display Materials, and Shanghai Engineering Research Center of Organ Repair, Shanghai University, Shanghai, 200444, C…
  • Guangzhou Municipal Key Laboratory of Materials Informatics, Sustainable Energy and Environment Thrust, Advanced Materials Thrust, Hong Kong University of Science and Technology (Guangzhou), Guangzhou, Guangdong, 511400…
  • School of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong, 226019, China.
  • National Clinical Research Center for Digestive Diseases, Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
  • Joint International Research Laboratory of Biomaterials and Biotechnology in Organ Repair, Ministry of Education, Shanghai, 200444, China.

ORCID-Profile: Lingyan Feng

Förderung

  • National Natural Science Foundation of China
  • Program for Distinguished Professor of Shanghai Universities (Oriental Scholars)
  • Guangzhou-HKUST(GZ) Joint Funding Program

Zitieren

APA

Li, T., Cao, B., Su, T., Lin, L., Wang, D., Liu, X., Wan, H., Ji, H., He, Z., Chen, Y., Feng, L., & Zhang, T. Y. (2025). Machine Learning‐Engineered Nanozyme System for Synergistic Anti‐Tumor Ferroptosis/Apoptosis Therapy. Small, 21(5). https://doi.org/10.1002/smll.202408750

Vancouver

Li T, Cao B, Su T, Lin L, Wang D, Liu X, et al. Machine Learning‐Engineered Nanozyme System for Synergistic Anti‐Tumor Ferroptosis/Apoptosis Therapy. Small. 2025;21(5). doi:10.1002/smll.202408750

BibTeX
@article{Li2025,
  author = {Li, Tianliang and Cao, Bin and Su, Tianhao and Lin, Lixing and Wang, Dong and Liu, Xinting and Wan, Haoyu and Ji, Haiwei and He, Zixuan and Chen, Yingying and Feng, Lingyan and Zhang, Tong-Yi},
  title = {Machine Learning‐Engineered Nanozyme System for Synergistic Anti‐Tumor Ferroptosis/Apoptosis Therapy},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {5},
  doi = {10.1002/smll.202408750}
}
Kostenlos starten →